| 000 | 01419 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517025900.0 | ||
| 264 | 0 | _c20160425 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1522-9645 | ||
| 024 | 7 |
_a10.1093/eurheartj/ehv134 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeferović, Petar M | |
| 245 | 0 | 0 |
_aClinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cJul 2015 |
||
| 300 |
_a1718-27, 1727a-1727c p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAutoimmunity _xphysiology |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xdiagnosis |
| 650 | 0 | 4 |
_aCardiomyopathy, Restrictive _xdiagnosis |
| 650 | 0 | 4 |
_aDiabetic Cardiomyopathies _xdiagnosis |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
| 650 | 0 | 4 |
_aHeart Failure _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xetiology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 650 | 0 | 4 |
_aVentricular Dysfunction _xdiagnosis |
| 700 | 1 | _aPaulus, Walter J | |
| 773 | 0 |
_tEuropean heart journal _gvol. 36 _gno. 27 _gp. 1718-27, 1727a-1727c |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/ehv134 _zAvailable from publisher's website |
| 999 |
_c24818441 _d24818441 |
||